Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Regains Nasdaq Compliance

NEW YORK (GenomeWeb) – Biocept said this morning that it received notification yesterday from the Nasdaq that it has regained compliance with the exchange's minimum bid listing requirement.

Nasdaq notified the company last November that it had failed to maintain the required $1 per share minimum bid price, and faced delisting if it did not regain compliance within a 180-day grace period.

To regain compliance, the company successfully maintained the minimum closing bid price for at least 10 consecutive business days.

In Wednesday morning trading, shares of Biocept were down about 1 percent to $1.67.